Related Experiment Video
Updated: Mar 21, 2026

05:23
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.7K
A CCL8 gradient drives breast cancer cell dissemination
E Farmaki1, I Chatzistamou2,3, V Kaza1
1Department of Drug Discovery and Biomedical Sciences, University of South Carolina, Columbia, SC, USA.
Oncogene
|May 17, 2016
Summary
Breast cancer cells spread through chemoattractant gradients. CCL8 (chemokine C-C motif ligand 8) drives metastasis by guiding cancer cell invasion, intravasation, and extravasation, offering new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer cell dissemination is a complex process.
- Chemoattractant gradients are implicated in cancer metastasis.
- The role of specific chemoattractants like CCL8 in breast cancer spread requires further elucidation.
Purpose of the Study:
- To investigate the role of CCL8 gradients in breast cancer cell dissemination.
- To determine how CCL8 influences key steps of the metastatic cascade.
- To explore the therapeutic potential of targeting CCL8 in breast cancer management.
Main Methods:
- Analysis of CCL8 concentration gradients in tumor microenvironments.
- In vitro and in vivo experiments manipulating CCL8 activity.
- Histological examination of tumors and metastatic sites.
- Assessment of cancer cell invasion, intravasation, and extravasation.
Main Results:
- A gradient of increasing CCL8 concentration was identified from the tumor epithelium to the periphery.
- CCL8 production is upregulated in stromal fibroblasts and metastatic tissues (lungs, brain).
- CCL8 manipulation affected tumor histology and promoted metastatic processes.
- Targeting CCL8 activity influenced cancer cell invasion, intravasation, and extravasation.
Conclusions:
- CCL8 gradients are instrumental in driving breast cancer cell dissemination.
- CCL8 plays a critical role in multiple stages of metastasis.
- Interference with CCL8 signaling presents a promising strategy for breast cancer treatment.
Related Concept Videos
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Chemotaxis and Direction of Cell Migration
6.1K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
6.1K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K

